FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8998160.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient whose primary tumor was a testicular teratocarcinoma predominantly composed of embryonal carcinoma. Before chemotherapy, the retroperitoneal metastases demonstrated heterogeneous, increased glucose metabolism as measured by 2-[18F]fluoro-2-deoxy-D-glucose and PET (FDG-PET). After chemotherapy, FDG uptake was reduced to normal values despite increased tumor volume. Histology revealed a pure mature teratoma. This observation suggests that further studies are needed to determine whether tumor differentiation of testicular teratocarcinoma metastases can be assessed by measuring glucose metabolism.
Medical subject headings
- Carcinoma, Embryonal
- Deoxyglucose
- Fluorine Radioisotopes
- Retroperitoneal Neoplasms
- Testicular Neoplasms
- Tomography, Emission-Computed